Short-term clinical and biochemical responses following treatment with dapagliflozin or ertugliflozin in horses with hyperinsulinemia: a retrospective case series. DOI Creative Commons
Tania Sundra,

Edd Knowles,

David Rendle

и другие.

Domestic Animal Endocrinology, Год журнала: 2024, Номер 90, С. 106894 - 106894

Опубликована: Ноя. 19, 2024

Язык: Английский

Potential adverse effects of SGLT2i in horses DOI
Bruce C. McGorum, John Keen, Sophie McCullagh

и другие.

Veterinary Record, Год журнала: 2024, Номер 195(6), С. 253 - 254

Опубликована: Сен. 20, 2024

Язык: Английский

Процитировано

0

SGLT2 inhibitors: Exploring the effects in humans and horses DOI
Tania Sundra, Vance B. Matthews, Patricia A. Harris

и другие.

Equine Veterinary Education, Год журнала: 2024, Номер unknown

Опубликована: Окт. 29, 2024

Summary Sodium‐glucose cotransporter 2 inhibitors (SGLT2i) are human antidiabetic drugs that increasingly used in equine practice for the management of hyperinsulinaemia and hyperinsulinaemia‐associated laminitis. However, understanding SGLT2i use horses is its infancy compared to medicine. This review article aims briefly examine literature both species, highlighting current knowledge gaps, potential similarities therapeutic outcomes possible adverse effects.

Язык: Английский

Процитировано

0

Short-term clinical and biochemical responses following treatment with dapagliflozin or ertugliflozin in horses with hyperinsulinemia: a retrospective case series. DOI Creative Commons
Tania Sundra,

Edd Knowles,

David Rendle

и другие.

Domestic Animal Endocrinology, Год журнала: 2024, Номер 90, С. 106894 - 106894

Опубликована: Ноя. 19, 2024

Язык: Английский

Процитировано

0